Levothyroxine Sodium
- Product NDC
- 70934-380
- 11-digit product format
- 709340380
- Labeler code
- 70934
- Product ID
- 70934-380_a12b4de7-6ca5-14b0-e053-2995a90a7f7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA209713
- Marketing category
- ANDA
- Marketing start
- 2019-06-03
- Marketing end
- 0000-00-00
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 0 mg/1
- Pharmacologic classes
- l-Thyroxine [EPC],Thyroxine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-380-30 | 70934038030 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-380-30) | 30 tablet | 2020-01-24 | 0000-00-00 | No | No | Current |
| 70934-380-90 | 70934038090 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-380-90) | 90 tablet | 2019-06-03 | 0000-00-00 | No | No | Current |
| 70934-380-97 | 70934038097 | 100 TABLET in 1 BOTTLE, PLASTIC (70934-380-97) | 100 tablet | 2019-09-03 | 0000-00-00 | No | No | Current |